Results 41 to 50 of about 30,963 (261)

Rifabutin-induced cystoid macular oedema [PDF]

Journal of Antimicrobial Chemotherapy, 2002
Rifabutin is a semi-synthetic antimycobacterial agent mainly used in the treatment of Mycobacterium avium-complex (MAC) in AIDS patients. Rifabutin-induced anterior uveitis has been reported previously. We report the case of a rifabutin-induced cystoid macular oedema (CMO) in an immunocompetent patient with pulmonary MAC infection.
Vaudaux, J.D., Guex-Crosier, Y.
openaire   +3 more sources

Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report [PDF]

, 2016
Background Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon ...
AGOSTINELLI, Enzo, CARLESIMO, Sandra Cinzia, Forastiere, Michele, NEBBIOSO, Marcella, PACELLA, Elena, PACELLA, FERNANDA, SECONDI, ROBERTO   +6 more
core   +1 more source

Bilateral multiple retinal artery macroaneurysms with coexistent diabetic retinopathy

TNOA Journal of Ophthalmic Science and Research, 2022
To discuss the clinical profile of retinal artery macroaneurysms (RAMs), its presentation, rarity, complexity in diagnosis and management modalities. RAMs are seen commonly in elderly females who have associated systemic hypertension.
Roshni Mohan, M Arthi
doaj   +1 more source

Fingolimod: therapeutic mechanisms and ocular adverse effects. [PDF]

, 2017
Fingolimod is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). We aim to review the published literature on ocular manifestations of fingolimod therapy and their possible underlying mechanisms.
A Groves, A Gupta, A Minuk, A Schwarz, AR Afshar, B Nealon, BJ McVerry, C Aguiar, D Ontaneda, G Saab, H Chen, H Tedesco-Silva, J Camm, J Chui, J Chun, JA Cohen, JA Cohen, JM Gelfand, K Schroder, K Turaka, L Kappos, L Kappos, L Liu, M Brar, M Salvadori, MA Zarbin, ML Oo, MT Bhatti, N Ueda, OJ Coppes, P A Keane, P Mandal, PA Calabresi, R Gallego-Pinazo, R Moosavi, RS Brush, S Thoo, V Li, VM Asensio-Sanchez, W Fusi-Rubiano, Y Yang   +40 more
core   +1 more source

Cyclic presentation of central macular oedema [PDF]

Acta Ophthalmologica Scandinavica, 1998
We present the case of a young lady with unilateral pars planitis and associated cystoid macular oedema in whom visual symptoms fluctuated regularly during successive menstrual cycles. To date no such presentation of central macular oedema has been reported in the literature.
A, Assi, J H, Casey, C, Davey, J, Crowston   +3 more
openaire   +2 more sources

IL-17A Damages the Blood–Retinal Barrier through Activating the Janus Kinase 1 Pathway

Biomedicines, 2021
Blood–retinal barrier (BRB) dysfunction underlies macular oedema in many sight-threatening conditions, including diabetic macular oedema, neovascular age-related macular degeneration and uveoretinitis.
Eimear M. Byrne, María Llorián-Salvador, Miao Tang, Andriana Margariti, Mei Chen, Heping Xu   +5 more
doaj   +1 more source

The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract [PDF]

, 2005
Background The management of diabetic patients with refractory macular oedema or patients with no adequate pre-operative view to administer laser treatment provide a challenge to the ophthalmologist.
Maged S Habib, Paul S Cannon, David HW Steel, F Ederer, R Klein, PG Hykin, A Ionides, S Kato, SA Sadiq, J Chung, Royal College of Ophthalmologists, IA Cunliffe, A Pollack, M Henricsson, GJ Jaffe, D Squirrell, JGF Dowler, A Zaczek, K Krepler, E Chew, D Chiu, WE Benson, RJ Ancliffe, JGF Dowler, EC Zweng, JB Jonas, A Martidis, P Massin, MD Conway, N Benhamou, CA Wilson, Early Treatment Diabetic Retinopathy Study Research Group, R Klein, RJ Wingate, JB Jonas, GB Jaissle, JK Challa, DM Moshfeghi, T Sakamoto, S Masket, SJ Morgan, SE Burk, M Lavin, T Sakamato, AN Antoszyk, RP Danis   +45 more
core   +2 more sources

The resistant macular oedema

Kathmandu University Medical Journal, 1970
DOI: 10.3126/kumj.v7i3.2721 Kathmandu University Medical Journal (2009) Vol.7, No.3 Issue 27, 192 ...
openaire   +3 more sources

Incidence of central involving macular oedema after cataract surgery in diabetic retinopathy patients – A prospective study

TNOA Journal of Ophthalmic Science and Research
Aim: To study the incidence of central macular oedema at 4, 8 and 12 weeks following cataract surgery in diabetic retinopathy eyes. Materials and Methods: A prospective observational study was conducted over a period of 3 months to investigate the ...
Sankari Alias Mansa Devi, V G Madhanagopalan   +1 more
doaj   +1 more source

Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema

Cells, 2021
Diabetic macular oedema (DMO) is one of the leading causes of vision loss associated with diabetic retinopathy (DR). New insights in managing this condition have changed the paradigm in its treatment, with intravitreal injections of antivascular ...
Milagros Mateos-Olivares, Luis García-Onrubia, Fco. Javier Valentín-Bravo, Rogelio González-Sarmiento, Maribel Lopez-Galvez, J. Carlos Pastor, Ricardo Usategui-Martín, Salvador Pastor-Idoate   +7 more
doaj   +1 more source